[The design and baseline characteristics of a phase III study to evaluate the efficacy and safety of alogliptin versus placebo in type 2 diabetes mellitus in Mainland China].

Pan, Chang-yu; Li, Wen-hui; Zeng, Jiao-e; Li, Cheng-jiang; Yang, Jin-kui; Ji, Qiu-he; Lu, Ju-ming; Lü, Xiao-feng; Li, Xue-feng; Qu, Shen; Xu, Xiang-jin; Xue, Yao-ming; Li, Ling; Jiang, Zhao-shun; Zheng, Bao-zhong; Bu, Rui-fang; Han, Ping; Liu, Yu; Liu, Jing-dong; Peng, Yong-de; Liu, Xiao-min; Liu, Zhi-min; Yan, Li; Lei, Min-xiang; Li, Xue-jun; Song, Qin-hua; Shi, Bing-yin; Gu, Wei; Li, Zheng-fang

Pan, Chang-yu; Li, Wen-hui; Zeng, Jiao-e; Li, Cheng-jiang; Yang, Jin-kui; Ji, Qiu-he; Lu, Ju-ming; Lü, Xiao-feng; Li, Xue-feng; Qu, Shen; Xu, Xiang-jin; Xue, Yao-ming; Li, Ling; Jiang, Zhao-shun; Zheng, Bao-zhong; Bu, Rui-fang; Han, Ping; Liu, Yu; Liu, Jing-dong; Peng, Yong-de; Liu, Xiao-min; Liu, Zhi-min; Yan, Li; Lei, Min-xiang; Li, Xue-jun; Song, Qin-hua; Shi, Bing-yin; Gu, Wei; Li, Zheng-fang.

Pan CY; Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China. Email: panchy301@aliyun.com.

Zhonghua Nei Ke Za Zhi ; 52(11): 932-5, 2013 Nov.

Article en Zh | MEDLINE | ID: mdl-24439186

Asunto(s)

Diabetes Mellitus Tipo 2/tratamiento farmacológico; Piperidinas/efectos adversos; Piperidinas/uso terapéutico; Uracilo/análogos & derivados; Adulto; China; Método Doble Ciego; Femenino; Humanos; Masculino; Persona de Mediana Edad; Estudios Prospectivos; Proyectos de Investigación; Resultado del Tratamiento; Uracilo/efectos adversos; Uracilo/uso terapéutico

Search on Google

Imprimir

XML

PubMed Links

Banco de datos: MEDLINE Asunto principal: Piperidinas / Uracilo / Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: Zh Año: 2013 Tipo del documento: Article

Search on Google

Imprimir

XML

PubMed Links